Vyas Tungaturti is a seasoned M&A operator and advisor specializing in large-scale mergers, acquisitions, and private equity due diligence. His experience spans integration and divestiture office leadership, complex cross-border transactions, and the application of AI and machine learning to deal execution. Founder of CorpDev.Org and builder of Kai, an AI due-diligence platform for deal teams, Vyas writes on deal intelligence, value creation, and how AI is reshaping M&A and PE workflows.
An Alaska Airlines executive testified Thursday in the government's antitrust trial challenging a JetBlue and American Airlines pact that he's never seen such cooperative terms between domestic...
Despite its rich oil history, California has become increasingly difficult for producers to operate in, with the state vowing to phase out oil extraction entirely by 2045.Such conditions are forcing...
Boasso provides mission-critical logistics services to the global chemical and food grade supply chains through a network of 34 strategically located depots across North America and Western Europe....
LEVERKUSEN, Germany--(BUSINESS WIRE)--Bayer has completed the sale of its Environmental Science Professional business to the international private equity firm Cinven, after the two companies had...
Cano shares, which had been down nearly 7%, turned positive and closed up 32% after The Wall Street Journal reported on the talks with Humana and other unnamed parties, giving the company a market...
A European private-equity firm agreed to buy a controlling stake in Eataly SpA, with the aim of helping the Italian-marketplace chain continue to expand globally. Source
Author: unknown
The special-purpose acquisition company trying to take Trump Media & Technology Group public will pay nearly $3 million to get three more months to complete the deal, tightening an already narrow...
Baker McKenzie partner Airi Hammalov shared her insights on cross-border trends in M&A for the second episode of The Deal’s Talking M&A podcast. The post Talking M&A: Cross-Border...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery,...
Big drivers of the investment wave were the substantial amount of fresh capital raised by fund managers in 2021, an increasing interest in Africa’s venture ecosystem and overall larger ticket...